Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-04-03

FDA Approved: LABETALOL HYDROCHLORIDE — Original Application (Fosun Pharma USA Inc.)

View source ↗

Summary

The FDA approved the original ANDA for labetalol hydrochloride (generic) by Fosun Pharma USA Inc., authorizing its marketing as a generic antihypertensive.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Labetalol Hydrochloride (Labetalol hydrochloride)

Snippet

ORIG AP for LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)